Leadhopping – and beyond

Structural novelty has depended for its discovery on a combination of experimental and virtual screening, where virtual screening has meant either docking into a receptor or pharmacophoric or two-dimensional similarity. In this review, leadhopping denotes a new, far more convenient and apparently quite as effective, set of virtual screening methods, all of which emphasise a much more detailed similarity in ligand shape than the pharmacophore approach. Furthermore, some of these leadhopping methods have been adapted to address much broader needs, such as accelerated and simplified lead optimisation, access to an unprecedented vast structural space, and even useful forecasts of off-target pharmacological effects in humans. These methods seem robust and automatable enough to be used directly by laboratory chemists.

[1]  C. E. Peishoff,et al.  A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.

[2]  R. Cramer,et al.  Prospective identification of biologically active structures by topomer shape similarity searching. , 1999, Journal of medicinal chemistry.

[3]  Ajay N. Jain,et al.  Robust ligand-based modeling of the biological targets of known drugs. , 2006, Journal of medicinal chemistry.

[4]  Ajay N. Jain,et al.  Parameter estimation for scoring protein-ligand interactions using negative training data. , 2006, Journal of medicinal chemistry.

[5]  S. Muchmore,et al.  The Use of Three‐Dimensional Shape and Electrostatic Similarity Searching in the Identification of a Melanin‐Concentrating Hormone Receptor 1 Antagonist , 2006, Chemical biology & drug design.

[6]  Robert D. Clark,et al.  Virtual Compound Libraries: A New Approach to Decision Making in Molecular Discovery Research , 1998, J. Chem. Inf. Comput. Sci..

[7]  Ajay N. Jain,et al.  Ligand-based structural hypotheses for virtual screening. , 2004, Journal of medicinal chemistry.

[8]  Schmid,et al.  "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.

[9]  J. G. Vinter,et al.  Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists. , 2005, Journal of medicinal chemistry.

[10]  Yvonne C. Martin,et al.  Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection , 1996, J. Chem. Inf. Comput. Sci..

[11]  K Jarnagin,et al.  Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. , 2001, Cancer research.

[12]  Robert J. Jilek,et al.  Topomers: A Validated Protocol for Their Self-Consistent Generation , 2004, J. Chem. Inf. Model..

[13]  G. Schneider,et al.  New Allosteric Modulators of Metabotropic Glutamate Receptor 5 (mGluR5) Found by Ligand‐Based Virtual Screening , 2005, Chembiochem : a European journal of chemical biology.

[14]  Naomie Salim,et al.  Analysis and Display of the Size Dependence of Chemical Similarity Coefficients , 2003, J. Chem. Inf. Comput. Sci..

[15]  J. Jenkins,et al.  A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. , 2004, Journal of medicinal chemistry.

[16]  Peter Willett,et al.  Scaffold Hopping Using Clique Detection Applied to Reduced Graphs , 2006, J. Chem. Inf. Model..

[17]  Robert J. Jilek,et al.  AllChem: generating and searching 1020 synthetically accessible structures , 2007, J. Comput. Aided Mol. Des..

[18]  R. Cramer,et al.  SUBSTRUCTURAL ANALYSIS, A NOVEL APPROACH TO THE PROBLEM OF DRUG DESIGN , 1974 .

[19]  J. A. Grant,et al.  A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.

[20]  Lars Naerum,et al.  Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors. , 2002, Bioorganic & medicinal chemistry letters.

[21]  Ian A. Watson,et al.  ErG: 2D Pharmacophore Descriptions for Scaffold Hopping. , 2006 .

[22]  Robert J. Jilek,et al.  "Lead hopping". Validation of topomer similarity as a superior predictor of similar biological activities. , 2004, Journal of medicinal chemistry.

[23]  Qiang Zhang,et al.  Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. , 2006, Journal of medicinal chemistry.

[24]  R. Cramer,et al.  Toward general methods of targeted library design: topomer shape similarity searching with diverse structures as queries. , 2000, Journal of medicinal chemistry.

[25]  R. Cramer,et al.  Topomer CoMFA: a design methodology for rapid lead optimization. , 2003, Journal of medicinal chemistry.

[26]  Maria A Miteva,et al.  Fast structure-based virtual ligand screening combining FRED, DOCK, and Surflex. , 2005, Journal of medicinal chemistry.

[27]  Andy Vinter,et al.  Molecular Field Extrema as Descriptors of Biological Activity: Definition and Validation , 2006, J. Chem. Inf. Model..

[28]  Robert D Clark,et al.  Bioisosterism as a molecular diversity descriptor: steric fields of single "topomeric" conformers. , 1996, Journal of medicinal chemistry.

[29]  Robert D Clark,et al.  Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. , 1996, Journal of medicinal chemistry.

[30]  S. Wold,et al.  Comparative molecular field analysis , 1991 .

[31]  B. Masek,et al.  Molecular shape comparison of angiotensin II receptor antagonists. , 1993, Journal of medicinal chemistry.

[32]  R. Cramer,et al.  Dbtop: topomer similarity searching of conventional structure databases. , 2002, Journal of molecular graphics & modelling.

[33]  Andrew C. Good,et al.  Descriptors you can count on? Normalized and filtered pharmacophore descriptors for virtual screening , 2004, J. Comput. Aided Mol. Des..

[34]  E. Jaeger,et al.  Comparison of automated docking programs as virtual screening tools. , 2005, Journal of Medicinal Chemistry.

[35]  P. Willett,et al.  A Comparison of Some Measures for the Determination of Inter‐Molecular Structural Similarity Measures of Inter‐Molecular Structural Similarity , 1986 .

[36]  G. S. Gill,et al.  Molecular surface point environments for virtual screening and the elucidation of binding patterns (MOLPRINT) , 2004 .

[37]  J. A. Grant,et al.  A Gaussian Description of Molecular Shape , 1995 .

[38]  Thomas Lengauer,et al.  Novel technologies for virtual screening. , 2004, Drug discovery today.

[39]  Jin Li,et al.  On Evaluating Molecular-Docking Methods for Pose Prediction and Enrichment Factors , 2006, J. Chem. Inf. Model..

[40]  Ajay N. Jain Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. , 2003, Journal of medicinal chemistry.

[41]  Lirong Chen,et al.  3D QSAR Analyses of Novel Tyrosine Kinase Inhibitors Based on Pharmacophore Alignment. , 2001 .

[42]  Andreas Evers,et al.  Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols. , 2005, Journal of medicinal chemistry.

[43]  Robert D. Clark,et al.  Structural Unit Analysis Identifies Lead Series and Facilitates Scaffold Hopping in Combinatorial Chemistry. , 2006 .